130 related articles for article (PubMed ID: 3626612)
1. Juvenile monosomy 7 syndrome: evidence that the disease originates in a pluripotent hemopoietic stem cell.
Hogge DE; Shannon KM; Kalousek DK; Schonberg S; Schaffner V; Zoger S; Eaves CJ; Eaves AC
Leuk Res; 1987; 11(8):705-9. PubMed ID: 3626612
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic evidence for involvement of erythroid and granulocyte/macrophage progenitors in an infant with monosomy 7 syndrome presenting de novo.
Tachibana N; Raimondi SC; Santana VM; Dow LW
Med Pediatr Oncol; 1988; 16(2):118-22. PubMed ID: 3352534
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic evidence for involvement of erythroid progenitors in a child with therapy linked myelodysplasia.
Grier HE; Weinstein HJ; Révész T; Houlihan PW; Greenhalgh CL; Nathan DG; Tantravahi R
Br J Haematol; 1986 Nov; 64(3):513-9. PubMed ID: 3466643
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cultures in dysmyelopoietic syndrome: diagnostic and prognostic evaluation.
Shihab-el-Deen A; Guevara C; Prchal JF
Acta Haematol; 1987; 78(1):17-22. PubMed ID: 3116803
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
[TBL] [Abstract][Full Text] [Related]
6. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings.
Brandwein JM; Horsman DE; Eaves AC; Eaves CJ; Massing BG; Wadsworth LD; Rogers PC; Kalousek DK
Am J Pediatr Hematol Oncol; 1990; 12(1):63-70. PubMed ID: 2309981
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tachibana N; Raimondi SC; Lauer SJ; Sartain P; Dow LW
Blood; 1987 Nov; 70(5):1458-61. PubMed ID: 3478100
[TBL] [Abstract][Full Text] [Related]
8. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
10. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic evidence for a clonal involvement of granulocyte-macrophage and erythroid lineages in a patient with refractory anaemia.
Okuda T; Yokota S; Maekawa T; Sonoda Y; Taniwaki M; Misawa S; Takino T; Abe T
Acta Haematol; 1988; 80(2):110-5. PubMed ID: 3138872
[TBL] [Abstract][Full Text] [Related]
12. Three-lineage hemopoietic precursor cells and effectiveness of recombinant human erythropoietin in patients with myelodysplastic syndromes.
Fukushima Y; Kanno Y; Miura AB
Tohoku J Exp Med; 1992 Mar; 166(3):375-85. PubMed ID: 1585347
[TBL] [Abstract][Full Text] [Related]
13. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
14. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic evidence for a clonal disorder involving CFU-GEMM, BFU-E and CFU-C in patients with myeloproliferative disorders.
Sugiyama H; Ichiba S; Okuno Y; Takahashi T; Imura H; Nakamura K; Iho S; Hoshino T; Okada T; Furukawa H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1022-32. PubMed ID: 2588952
[TBL] [Abstract][Full Text] [Related]
17. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
[TBL] [Abstract][Full Text] [Related]
18. Childhood erythroleukemia. Studies on pathogenesis using colony assays.
Freedman MH; Chan HS; Chang L
Am J Pediatr Hematol Oncol; 1986; 8(1):2-7. PubMed ID: 3459376
[TBL] [Abstract][Full Text] [Related]
19. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
[TBL] [Abstract][Full Text] [Related]
20. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
